SAS-B approvals exceed 20,000 for third successive month by Steve Jones August 6, 2026August 6, 2026 Prescriptions through the Special Access Scheme hit the second highest of the year in July with […]
SAS-B deep dive: June hits new record for TGA approvals as pastilles surge and oil declines by Steve Jones July 8, 2026July 8, 2026
Pastilles surge again as SAS-B data shows strong start to 2026 by Steve Jones February 2, 2026February 3, 2026
Pastilles climb past oil to become second largest SAS-B dosage form by Steve Jones December 2, 2025December 4, 2025
October SAS-B approvals hit second highest number on record by Steve Jones November 3, 2025November 4, 2025
Pastilles overtake oil among 18-44 age group as SAS-B approvals near 2024 total by Steve Jones October 1, 2025October 1, 2025
July SAS-B approvals edge higher as pastilles share rises beyond 20% by Adam Sheldon August 5, 2025August 6, 2025
Two-month total of SAS-B approvals up 47% on 2024, TGA data shows by Steve Jones March 4, 2025April 1, 2025
Growth of pastilles accelerates as SAS approvals get off to strong start in 2025 by Steve Jones February 17, 2025February 17, 2025
May SAS-B approvals hold steady as THC-only product remains dominant by Steve Jones June 3, 2024June 3, 2024
